Literature DB >> 9357320

A three-state receptor model of agonist action.

P Leff1, C Scaramellini, C Law, K McKechnie.   

Abstract

The concept that receptors can exist in multiple conformational states is becoming a physical reality. A fundamental question is how many active states need to be proposed in order to account for pharmacological observations, in particular, the finding that the same receptor type can exhibit a different agonist pharmacology when coupled to different effector pathways. In this article, Paul Leff, Clare Scaramellini, Clare Law and Ken McKechnie propose and develop a three-state receptor model in which two active conformations are assumed to exist. They show that this relatively simple theoretical model provides a basis for predicting variable agonist and inverse agonist behaviour in different systems containing the same receptor, and that it is able to account for emerging data obtained on promiscuously coupled receptors. It is argued that, while these new theoretical considerations challenge the fundamental assumptions and concepts of traditional receptor theory, the general principles of pharmacological receptor classification are largely preserved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357320     DOI: 10.1016/s0165-6147(97)01105-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  34 in total

1.  The little difference: in vivo analysis of pheromone discrimination in Schizophyllum commune.

Authors:  Susanne Gola; Erika Kothe
Journal:  Curr Genet       Date:  2002-12-12       Impact factor: 3.886

Review 2.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

Review 3.  Ligand bias prevents class equality among beta-blockers.

Authors:  Vaidehi J Thanawala; Gloria S Forkuo; Wayne Stallaert; Paul Leff; Michel Bouvier; Richard Bond
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

4.  Mechanisms of inverse agonist action at D2 dopamine receptors.

Authors:  David J Roberts; Philip G Strange
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 5.  Modelling spatio-temporal interactions within the cell.

Authors:  Padmini Rangamani; Ravi Iyengar
Journal:  J Biosci       Date:  2007-01       Impact factor: 1.826

6.  What systems can and can't do.

Authors:  T Kenakin
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

7.  Modelling of the activation of G-protein coupled receptors: drug free constitutive receptor activity.

Authors:  P J Woodroffe; L J Bridge; J R King; C Y Chen; S J Hill
Journal:  J Math Biol       Date:  2009-04-05       Impact factor: 2.259

8.  Analysis of the atypical characteristics of adenosine receptors mediating negative inotropic and chronotropic responses of guinea-pig isolated atria and papillary muscles.

Authors:  N M Gardner; K J Broadley
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

9.  Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Authors:  Laura C Sullivan; William P Clarke; Kelly A Berg
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

10.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.